Baldwin Insurance Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Baldwin Insurance Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.50B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $980.72M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $567.29M | Feb 28, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.38B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.21B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $980.72M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $567.29M | Feb 28, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($33.81M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($24.52M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($90.14M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($41.77M) | Feb 25, 2025 |
| FY2021 | Dec 31, 2021 | ($22.65M) | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | ($13.21M) | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | ($10.09M) | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $15.31M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | ($10.31M) | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | ($3.27M) | Mar 11, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.94M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $60.65M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($42.55M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($31.10M) | Feb 25, 2025 |
| FY2021 | Dec 31, 2021 | ($37.86M) | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | ($17.18M) | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | ($13.54M) | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | $36.95M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | ($13.76M) | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | ($6.67M) | Mar 11, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.86B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.53B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.50B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.46B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.88B | Feb 28, 2023 |
| FY2021 | Jan 1, 2021 | $1.59B | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $1.53B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $398.77M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $139.83M | Mar 24, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.78B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.53B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.48B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $2.32B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.69B | Feb 28, 2023 |
| FY2021 | Jan 1, 2021 | $814.43M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $759.95M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $161.49M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $117.02M | Mar 24, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $600.22M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $583.22M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $560.41M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $608.10M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $608.38M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $367.78M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $73.29M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($63.70M) | Mar 24, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 1, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.67M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $90.05M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $116.21M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $118.09M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $138.29M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $108.46M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $67.69M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $8.00M | Mar 24, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $399.00M | Mar 11, 2021 |